The Association Among Medication Beliefs, Perception of Illness and Medication Adherence in Ischemic Stroke Patients: A Cross-Sectional Study in China

References

• Johnson CO, Nguyen M, Roth GA, et al. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):439–458. doi:10.1016/S1474-4422(19)30034-1
   PubMed Web of Science ®Google Scholar
• Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009;8(4):345–354. doi:10.1016/S1474-4422(09)70023-7
   PubMed Web of Science ®Google Scholar
• Chen Z. The mortality and death cause of national sample areas. Third National Surv Cause Death. 2008;1:14–15.
   Google Scholar
• Liu L, Wang D, Wong KL, Wang Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke. 2011;42(12):3651–3654. doi:10.1161/STROKEAHA.111.635755
   PubMed Web of Science ®Google Scholar
• Sun H, Zou X, Liu L. Epidemiological factors of stroke: a survey of the current status in China. J Stroke. 2013;15(2):109. doi:10.5853/jos.2013.15.2.109
   PubMed Web of Science ®Google Scholar
• Feng W, Hendry RM, Adams RJ. Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients. Neurology. 2010;74(7):588–593. doi:10.1212/WNL.0b013e3181cff776
   PubMed Web of Science ®Google Scholar
• Coull A, Lovett J, Rothwell P. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ. 2004;328(7435):326. doi:10.1136/bmj.37991.635266.44
   PubMed Web of Science ®Google Scholar
• Glader E-L, Sjölander M, Eriksson M, Lundberg M. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke. 2010;41(2):397–401. doi:10.1161/STROKEAHA.109.566950
   PubMed Web of Science ®Google Scholar
• Bushnell C, Olson D, Zhao X, et al. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology. 2011;77(12):1182–1190. doi:10.1212/WNL.0b013e31822f0423
   PubMed Web of Science ®Google Scholar
• Kucukarslan SN. A review of published studies of patients’ illness perceptions and medication adherence: lessons learned and future directions. Res Social Adm Pharm. 2012;8(5):371–382. doi:10.1016/j.sapharm.2011.09.002
   PubMed Web of Science ®Google Scholar
• Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cognit Ther Res. 1992;16(2):143–163. doi:10.1007/BF01173486
   Web of Science ®Google Scholar
• Furze G. Cardiac misconceptions: a problem in need of treatment. Pract Cardiovasc Risk Manag. 2007;5:13–15.
   Google Scholar
• Chen S-L, Tsai J-C, Chou K-R. Illness perceptions and adherence to therapeutic regimens among patients with hypertension: a structural modeling approach. Int J Nurs Stud. 2011;48(2):235–245. doi:10.1016/j.ijnurstu.2010.07.005
   PubMed Web of Science ®Google Scholar
• Tucker JD, Cheng Y, Wong B, et al. Patient–physician mistrust and violence against physicians in Guangdong Province, China: a qualitative study. BMJ Open. 2015;5(10):e008221. doi:10.1136/bmjopen-2015-008221
   PubMed Web of Science ®Google Scholar
• Wei L, Champman S, Li X, et al. Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China. BMJ Open. 2017;7(10):e017293. doi:10.1136/bmjopen-2017-017293
   PubMed Web of Science ®Google Scholar
• Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS One. 2013;8(12):e80633. doi:10.1371/journal.pone.0080633
   PubMed Web of Science ®Google Scholar
• Sun T-K, Chiu S-C, Yeh S-H, Chang K-C. Assessing reliability and validity of the Chinese version of the stroke scale: scale development. Int J Nurs Stud. 2006;43(4):457–463. doi:10.1016/j.ijnurstu.2005.07.004
   Web of Science ®Google Scholar
• Ng TS. Brief illness perception questionnaire (Brief IPQ). J Physiother. 2012;58(3):202. doi:10.1016/S1836-9553(12)70116-9
   Google Scholar
• Miyazaki M, Nakashima A, Nakamura Y, et al. Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: an observational cross-sectional pilot study. PLoS One. 2018;13(9):e0204814. doi:10.1371/journal.pone.0204814
   PubMed Web of Science ®Google Scholar
• Sjölander M, Eriksson M, Glader E-L. The association between patients’ beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey. BMJ Open. 2013;3(9):e003551. doi:10.1136/bmjopen-2013-003551
   PubMed Web of Science ®Google Scholar
• Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–637. doi:10.1016/j.jpsychores.2005.10.020
   PubMed Web of Science ®Google Scholar
• Lin Y-P, Chiu K-M, Wang T-J. Reliability and validity of the Chinese version of the brief illness perception questionnaire for patients with coronary heart disease. J Orient Inst Technol. 2011;2(31):145–155.
   Google Scholar
• Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–567. doi:10.1016/S0022-3999(99)00057-4
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24. doi:10.1080/08870449908407311
   Web of Science ®Google Scholar
• Lyu Y, Li Z, Han My MX, Cheng G. An Fr. The reliability and validity of the Chinese version of beliefs about medical questionnaire among elderly patients with depressive disorder. Chin J Nurs. 2014;4:002.
   Google Scholar
• Mahler C, Hermann K, Horne R, et al. Assessing reported adherence to pharmacological treatment recommendations. Translation and evaluation of the Medication Adherence Report Scale (MARS) in Germany. J Eval Clin Pract. 2010;16(3):574–579. doi:10.1111/j.1365-2753.2009.01169.x
   PubMed Web of Science ®Google Scholar
• Horne R. Measuring adherence: the case for self-report. Int J Behav Med. 2004;11:75.
   Google Scholar
• Tian Q, Yu L. Reliability and validity of the Chinese version of medication adherence report scale for asthma. Chin J Nurs. 2014;49(5):621–624.
   Google Scholar
• Peat J, Barton B. Medical Statistics: a Guide to Data Analysis and Critical Appraisal. John Wiley & Sons; 2008.
   Google Scholar
• Hayes AF. Introduction to Mediation, Moderation, and Conditional Process Analysis: a Regression-Based Approach. Guilford Publications; 2017.
   Google Scholar
• Guedes DT, Vafaei A, Alvarado BE, et al. Experiences of violence across life course and its effects on mobility among participants in the international mobility in aging study. BMJ Open. 2016;6(10):e012339. doi:10.1136/bmjopen-2016-012339
   Web of Science ®Google Scholar
• Preacher KJ, Hayes AF. SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput. 2004;36(4):717–731. doi:10.3758/BF03206553
   PubMedGoogle Scholar
• Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;40(3):879–891. doi:10.3758/BRM.40.3.879
   PubMed Web of Science ®Google Scholar
• Brott T, Adams Jr HP, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864–870. doi:10.1161/01.STR.20.7.864
   PubMed Web of Science ®Google Scholar
• Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15. doi:10.1136/bmj.38875.675486.55
   PubMed Web of Science ®Google Scholar
• Phatak HM, Thomas III J. Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann Pharmacother. 2006;40(10):1737–1742. doi:10.1345/aph.1H153
   PubMed Web of Science ®Google Scholar
• Chambers JA, O’Carroll RE, Hamilton B, et al. Adherence to medication in stroke survivors: a qualitative comparison of low and high adherers. Br J Health Psychol. 2011;16(3):592–609. doi:10.1348/2044-8287.002000
   PubMed Web of Science ®Google Scholar
• Sangsongrit N, Pinyopasakul W, Ayuthya SKN, Sriprasong S, Nilanont Y. Predictors of medication adherence in ischemic stroke patients. Nurs J (Manila). 2014;41(2):61–71.
   Google Scholar
• O’carroll R, Whittaker J, Hamilton B, Johnston M, Sudlow C, Dennis M. Predictors of adherence to secondary preventive medication in stroke patients. Ann Behav Med. 2010;41(3):383–390. doi:10.1007/s12160-010-9257-6
   Web of Science ®Google Scholar
• Kronish IM, Edmondson D, Goldfinger JZ, Fei K, Horowitz CR. Posttraumatic stress disorder and adherence to medications in survivors of strokes and transient ischemic attacks. Stroke. 2012;43(8):2192–2197. doi:10.1161/STROKEAHA.112.655209
   PubMed Web of Science ®Google Scholar
• Krauskopf K, Federman AD, Kale MS, et al. Chronic obstructive pulmonary disease illness and medication beliefs are associated with medication adherence. COPD. 2015;12(2):151–164. doi:10.3109/15412555.2014.922067
   PubMedGoogle Scholar
• Sofianou A, Martynenko M, Wolf MS, et al. Asthma beliefs are associated with medication adherence in older asthmatics. J Gen Intern Med. 2013;28(1):67–73. doi:10.1007/s11606-012-2160-z
   PubMed Web of Science ®Google Scholar
• Leaungsomnapa Y, Promproh S, Leaungsomnapa S, Sourthao Y. Influence of beliefs about medication on high group of medication adherence in hypertensive patients. J Prapokklao Hosp Clin Med Educ Center. 2013;30(2):146–157.
   Google Scholar
• Chan M, Mok E, Wong Y, et al. Attitudes of Hong Kong Chinese to traditional Chinese medicine and Western medicine: survey and cluster analysis. Complement Ther Med. 2003;11(2):103–109. doi:10.1016/S0965-2299(03)00044-X
   Web of Science ®Google Scholar
• Wei J-C-C, Su Y-C, Chang H-C, Jan M-S, Wong R-H, Chou C-T. Patient attitudes toward western medicine and the future of Chinese medicine for spondyloarthritis. Curr Rheumatol Rev. 2008;4(2):120–123. doi:10.2174/157339708784310275
   Google Scholar
• Kronish IM, Diefenbach MA, Edmondson DE, Phillips LA, Fei K, Horowitz CR. Key barriers to medication adherence in survivors of strokes and transient ischemic attacks. J Gen Intern Med. 2013;28(5):675–682.
   PubMed Web of Science ®Google Scholar
• Mahler C, Hermann K, Horne R, Jank S, Haefeli WE, Szecsenyi J. Patients’ beliefs about medicines in a primary care setting in Germany. J Eval Clin Pract. 2012;18(2):409–413. doi:10.1111/j.1365-2753.2010.01589.x
   Web of Science ®Google Scholar
• Emilsson M, Gustafsson PA, Öhnström G, Marteinsdottir I. Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry. 2017;26(5):559–571. doi:10.1007/s00787-016-0919-1
   PubMed Web of Science ®Google Scholar
• Gadkari AS, McHorney CA. Unintentional non-adherence to chronic prescription medications: how unintentional is it really? BMC Health Serv Res. 2012;12(1):98. doi:10.1186/1472-6963-12-98
   PubMed Web of Science ®Google Scholar
• Chao J, Nau DP, Aikens JE, et al. The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes. Res Social Adm Pharm. 2005;1(4):508–525. doi:10.1016/j.sapharm.2005.09.002
   PubMedGoogle Scholar
• Le TT, Bilderback A, Bender B, et al. Do asthma medication beliefs mediate the relationship between minority status and adherence to therapy? J Asthma. 2008;45(1):33–37. doi:10.1080/02770900701815552
   PubMed Web of Science ®Google Scholar
• Jiang Y, Ni W. Estimating the impact of adherence to and persistence with atypical antipsychotic therapy on health care costs and risk of hospitalization. Pharmacother: J Hum Pharmacol Drug Ther. 2015;35(9):813–822. doi:10.1002/phar.2015.35.issue-9
   Google Scholar